0

<< Emergency Department Management Of Calcium-Channel Blocker, Beta Blocker, And Digoxin Toxicity

Introduction

The prevalence of cardiovascular disease is increasing, due to the aging population,1 with cardiovascular medications (especially calcium-channel blockers and beta blockers) now some of the most prescribed therapeutic agents on the market.2 As a result of the growing use and availability of cardiovascular medications, there has been a rise in the number of toxic exposures. The 2011 annual report of the American Association of Poison Control Centers found that cardiovascular medications accounted for 102,766 exposures (3.74% of all exposures reported) and nearly 11% of fatalities.

To read the rest of this section, choose one of the options below.

Already purchased this course?
Log in to read.
Purchase a subscription

Price: $449/year

140+ Credits!

Money-back Guarantee
Get Quick-Read Evidence-Based Updates
Enter your email to get free evidence-based content delivered to your inbox once per month.
Please provide a valid email address.